Understanding Kidney Transplant Outcomes for Patients of African Ancestry
Official title: 1/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center
Funded at University of Wisconsin-Madison · NIH-11143752 · Data updated 2026-11-12
This research helps us understand why some kidney transplants from donors of African ancestry might not last as long, so we can improve outcomes for patients.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project start | September 25, 2017 |
| Project end | May 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $168,000 |
| NIH project number | 5U01DK116092-08 |
| Project ID | NIH-11143752 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients who have received a kidney transplant, especially those from African American donors, or living kidney donors of recent African ancestry, are relevant to this research.
✕Less likely to help
Patients receiving kidney transplants from European-American donors without the specific APOL1 high-risk genotypes may not directly benefit from this particular genetic focus.
What this research studies
We know that kidney transplants from deceased donors of African American background, especially those with certain APOL1 gene types, sometimes don't last as long. However, some patients do very well with these kidneys. This project aims to discover why these differences occur by looking at how APOL1 genes interact with other factors in the body and environment. We are also looking at living donors of recent African ancestry to understand their risks after donation. Our goal is to gather long-term information on kidney function and survival to better understand these genetic and environmental influences.
Why it matters
Potential benefit: If successful, this work could lead to better ways to match donors and recipients, or new treatments to help kidney transplants last longer for patients of African ancestry.
How similar studies have gone: This project is part of an established NIH consortium (APOLLO) that has been collecting data since 2017, building upon existing knowledge in the field of kidney transplantation genetics.
Where this research is happening
-
University of Wisconsin-Madison
Madison, United States Active
Researchers
- Principal investigator: Astor, Brad C — University of Wisconsin-Madison
- Study coordinator: Astor, Brad C
Related research
Other NIH-funded projects on the same topics.
-
Strategies for HIV-to-HIV kidney transplants to increase organ donations
This project looks at making HIV-to-HIV kidney transplantation more common to help people with HIV get transplants faster by boosting organ donation and changing practice.
-
Biomarker-guided Immunosuppression in Kidney Transplant Patients
A multicenter study in kidney transplant recipients is testing whether a biomarker score from HLA-DR/DQ can guide changes in immunosuppression to reduce rejection risk and drug toxicity.
-
Helping the immune system accept a donated kidney in patients without prior sensitization
This project will try giving specially treated donor B cells alongside immune-sparing medicines to teach the immune systems of kidney transplant patients without prior antibodies to accept the new kidney.
-
Lowering donor-specific antibodies in sensitized kidney transplant patients
This project works to reduce harmful donor-specific antibodies in people who are sensitized and need a kidney transplant so their new organ lasts longer.
-
Reducing geographic disparities in kidney transplant access with AI and operations research
Aiming to use AI and operations research to make kidney transplant access more fair across different regions in the U.S.
-
Centralized patient coaching to boost live donor kidney transplantation
A US-wide program trains patients, caregivers, and their networks with coaching to help them pursue living donor kidney transplantation.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.